Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Short-Term Debt issuances (2023 - 2025)

Rxo (RXO) has disclosed Short-Term Debt issuances for 3 consecutive years, with $95.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short-Term Debt issuances rose 171.43% year-over-year to $95.0 million, compared with a TTM value of $566.0 million through Dec 2025, up 137.82%, and an annual FY2025 reading of $566.0 million, up 137.82% over the prior year.
  • Short-Term Debt issuances was $95.0 million for Q4 2025 at Rxo, down from $210.0 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $300.0 million in Q1 2025 and bottomed at -$39.0 million in Q2 2025.
  • Average Short-Term Debt issuances over 3 years is $97.8 million, with a median of $80.0 million recorded in 2024.
  • Peak annual rise in Short-Term Debt issuances hit 669.23% in 2025, while the deepest fall reached 148.75% in 2025.
  • Year by year, Short-Term Debt issuances stood at $76.0 million in 2023, then tumbled by 53.95% to $35.0 million in 2024, then skyrocketed by 171.43% to $95.0 million in 2025.
  • Business Quant data shows Short-Term Debt issuances for RXO at $95.0 million in Q4 2025, $210.0 million in Q3 2025, and -$39.0 million in Q2 2025.